// App-Quantinova.ai

P225 : Day of admission results predict failure of first-line treatment in acute ulcerative colitis

Researchers

Presenter

  • R Grant

Principal Investigators

  • R Lynch

  • S Bouri

  • A Elosua Gonzlez

  • T Manship

  • F Jagger

  • M Shivakumar

  • J Satsangi

  • G-T Ho

  • C Lees

  • N Plevris

  • P Tozer

  • A Hart

  • I Arnott

Medical Centers

  • Royal Infirmary of Edinburgh, Edinburgh, Edinburgh, UK

  • St Mark's Hospital, Harrow, London, UK

  • Complejo Hospitalario de Navarra, Pamplona, Spain

  • Western General Hospital, Edinburgh, United Kingdom

  • University of Edinburgh, Edinburgh, UK

  • OCDEM, University of Oxford, Oxford, UK

Locations

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • C reactive protein

  • Human albumin

Drug/Treatment

  • Cyclosporine A

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved